Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.
Abdallah CG, Averill LA, Gueorguieva R, Goktas S, Purohit P, Ranganathan M, Sherif M, Ahn KH, D'Souza DC, Formica R, Southwick SM, Duman RS, Sanacora G, Krystal JH.
Abdallah CG, et al.
Neuropsychopharmacology. 2020 May;45(6):990-997. doi: 10.1038/s41386-020-0644-9. Epub 2020 Feb 24.
Neuropsychopharmacology. 2020.
PMID: 32092760
Free PMC article.
Clinical Trial.